Status:
UNKNOWN
DAta MIning to Evaluate Novasure Treatment
Lead Sponsor:
Maxima Medical Center
Collaborating Sponsors:
Utrecht University
Conditions:
Abnormal Uterine Bleeding
Eligibility:
FEMALE
Brief Summary
Abnormal Uterine Bleeding (AUB) is a common health problem that affects approximately 30% of women of reproductive age and can have several underlying causes. It significantly affects quality of life,...
Detailed Description
Ten-year retrospective single-center cohort study in which we will: 1. retrospectively follow patients who underwent endometrial ablation using Novasure between 2009-2019 at the Máxima Medical Center...
Eligibility Criteria
Inclusion
- Women who suffer from AUB and who previously underwent Novasure treatment between 2008-2018 in MMC.
Exclusion
- Previous Novasure for AUB.
Key Trial Info
Start Date :
July 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2025
Estimated Enrollment :
1038 Patients enrolled
Trial Details
Trial ID
NCT05299801
Start Date
July 1 2021
End Date
July 1 2025
Last Update
March 29 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Máxima Medical Center
Veldhoven, Netherlands